Главная
Study mode:
on
1
Introduction
2
Introductions
3
Vaccine skepticism
4
Polling data
5
Trust and confidence
6
Information war
7
Importance of vaccines
8
Public health and vaccines
9
Vaccine constructs
10
A good news story
11
Challenges of vaccine development
12
Are there any corners cut
13
Why clinical trials matter
14
Will the vaccine protect us as the virus evolves
15
How long does the antibody response last
16
Five vaccines require two doses
17
Should people with COVID19 get the vaccine
18
Postmarketing surveillance
19
Real world data
20
What the FDA does
21
FDAs workload
Description:
Explore the intricate process of vaccine development, from research and development to FDA authorization and approval, in this 48-minute talk from The Aspen Institute. Gain insights from former FDA Commissioner Dr. Peggy Hamburg and current FDA Commissioner Dr. Stephen Hahn as they discuss the challenges of developing COVID-19 vaccines at "warp speed" while ensuring safety and efficacy. Delve into topics such as vaccine skepticism, public trust, the importance of clinical trials, and the FDA's role in vaccine approval. Learn about the complexities of vaccine constructs, antibody response duration, and the need for multiple doses. Understand the significance of postmarketing surveillance and real-world data in monitoring vaccine safety and effectiveness. This comprehensive discussion, moderated by Fortune's Editor-in-Chief Clifton Leaf, provides a valuable inside look at the vaccine development process and addresses key concerns surrounding COVID-19 vaccines.

From R&D to FDA Authorization and Approval: An Inside Look at the Vaccine Development Process

The Aspen Institute
Add to list
0:00 / 0:00